Amlopres 5

Overview Clinical Studies Authored by Reviewed by References

Overview

Marketed by:
Cipla Limited

Manufactured By :
Cipla Limited

Medicine Type :
Allopathy

Prescription Type :
Prescription Required

Approval :
DCGI (Drugs Controller General of India)

Pharmacological Class :

Calcium channel blocker,

Therapy Class:

Antihypertensive,

Schedule :
Schedule H

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf

https://www.uptodate.com/contents/amlodipine-drug-information

https://go.drugbank.com/drugs/DB00381

https://www.drugs.com/amlodipine.html

https://medlineplus.gov/druginfo/meds/a692044.html

https://reference.medscape.com/drug/katerzia-norvasc-amlodipine-342372

https://www.rxlist.com/consumer_amlodipine_norvasc/drugs-condition.html

Authored by

Dr. Binil Benny

Binil Benny is a doctor of Pharmacy graduate and is currently working as a content writer at Medical Dialogues. He has in-depth knowledge of pharmacology and oncotherapeutics. He can be contacted at editorial@medicaldialogues.in.

Reviewed by

Dr JUHI SINGLA

Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Page Created On: 12 Nov 2022 9:50 AM GMT

Page Last Updated On: 2023-04-01 09:05:59.0